106 related articles for article (PubMed ID: 12387860)
1. Specificity of substrate recognition by type II dehydroquinases as revealed by binding of polyanions.
Evans LD; Roszak AW; Noble LJ; Robinson DA; Chalk PA; Matthews JL; Coggins JR; Price NC; Lapthorn AJ
FEBS Lett; 2002 Oct; 530(1-3):24-30. PubMed ID: 12387860
[TBL] [Abstract][Full Text] [Related]
2. The folding and assembly of the dodecameric type II dehydroquinases.
Price NC; Boam DJ; Kelly SM; Duncan D; Krell T; Gourley DG; Coggins JR; Virden R; Hawkins AR
Biochem J; 1999 Feb; 338 ( Pt 1)(Pt 1):195-202. PubMed ID: 9931316
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and structural studies on potent biaryl inhibitors of type II dehydroquinases.
Payne RJ; Riboldi-Tunnicliffe A; Kerbarh O; Abell AD; Lapthorn AJ; Abell C
ChemMedChem; 2007 Jul; 2(7):1010-3. PubMed ID: 17487901
[No Abstract] [Full Text] [Related]
4. Mechanistic studies on type I and type II dehydroquinase with (6R)- and (6S)-6-fluoro-3-dehydroquinic acids.
Parker EJ; González Bello C; Coggins JR; Hawkins AR; Abell C
Bioorg Med Chem Lett; 2000 Feb; 10(3):231-4. PubMed ID: 10698442
[TBL] [Abstract][Full Text] [Related]
5. (1R,4S,5R)-3-Fluoro-1,4,5-trihydroxy-2-cyclohexene-1-carboxylic acid: the fluoro analogue of the enolate intermediate in the reaction catalyzed by type II dehydroquinases.
Frederickson M; Roszak AW; Coggins JR; Lapthorn AJ; Abell C
Org Biomol Chem; 2004 Jun; 2(11):1592-6. PubMed ID: 15162210
[TBL] [Abstract][Full Text] [Related]
6. Structures of native, substrate-bound and inhibited forms of Mycobacterium tuberculosis imidazoleglycerol-phosphate dehydratase.
Ahangar MS; Vyas R; Nasir N; Biswal BK
Acta Crystallogr D Biol Crystallogr; 2013 Dec; 69(Pt 12):2461-7. PubMed ID: 24311587
[TBL] [Abstract][Full Text] [Related]
7. The structure and mechanism of the type II dehydroquinase from Streptomyces coelicolor.
Roszak AW; Robinson DA; Krell T; Hunter IS; Fredrickson M; Abell C; Coggins JR; Lapthorn AJ
Structure; 2002 Apr; 10(4):493-503. PubMed ID: 11937054
[TBL] [Abstract][Full Text] [Related]
8. Understanding the key factors that control the inhibition of type II dehydroquinase by (2R)-2-benzyl-3-dehydroquinic acids.
Peón A; Otero JM; Tizón L; Prazeres VF; Llamas-Saiz AL; Fox GC; van Raaij MJ; Lamb H; Hawkins AR; Gago F; Castedo L; González-Bello C
ChemMedChem; 2010 Oct; 5(10):1726-33. PubMed ID: 20815012
[TBL] [Abstract][Full Text] [Related]
9. Irreversible inhibition of type I dehydroquinase by substrates for type II dehydroquinase.
Bello CG; Harris JM; Manthey MK; Coggins JR; Abell C
Bioorg Med Chem Lett; 2000 Mar; 10(5):407-9. PubMed ID: 10743936
[TBL] [Abstract][Full Text] [Related]
10. The Mycobacterium tuberculosis shikimate pathway genes: evolutionary relationship between biosynthetic and catabolic 3-dehydroquinases.
Garbe T; Servos S; Hawkins A; Dimitriadis G; Young D; Dougan G; Charles I
Mol Gen Genet; 1991 Sep; 228(3):385-92. PubMed ID: 1910148
[TBL] [Abstract][Full Text] [Related]
11. Insights into Substrate Modification by Dehydratases from Type I Polyketide Synthases.
Faille A; Gavalda S; Slama N; Lherbet C; Maveyraud L; Guillet V; Laval F; Quémard A; Mourey L; Pedelacq JD
J Mol Biol; 2017 May; 429(10):1554-1569. PubMed ID: 28377293
[TBL] [Abstract][Full Text] [Related]
12. 2-substituted-3-dehydroquinic acids as potent competitive inhibitors of type II dehydroquinase.
Prazeres VF; Castedo L; Lamb H; Hawkins AR; González-Bello C
ChemMedChem; 2009 Dec; 4(12):1980-4. PubMed ID: 19856378
[No Abstract] [Full Text] [Related]
13. Evidence that the active site in type II dehydroquinase from Streptomyces coelicolor is near the single tryptophan.
Boam DJ; Price NC; Kelly SM; Krell T; Coggins JR
Biochem Soc Trans; 1997 Feb; 25(1):348; replaces 93S. PubMed ID: 9147947
[No Abstract] [Full Text] [Related]
14. Inhibitors of types I and II dehydroquinase.
Le Sann C; Gower MA; Abell AD
Mini Rev Med Chem; 2004 Sep; 4(7):747-56. PubMed ID: 15379642
[TBL] [Abstract][Full Text] [Related]
15. Localization of the active site of type II dehydroquinases. Identification of a common arginine-containing motif in the two classes of dehydroquinases.
Krell T; Horsburgh MJ; Cooper A; Kelly SM; Coggins JR
J Biol Chem; 1996 Oct; 271(40):24492-7. PubMed ID: 8798709
[TBL] [Abstract][Full Text] [Related]
16. Crystal structures of Helicobacter pylori type II dehydroquinase inhibitor complexes: new directions for inhibitor design.
Robinson DA; Stewart KA; Price NC; Chalk PA; Coggins JR; Lapthorn AJ
J Med Chem; 2006 Feb; 49(4):1282-90. PubMed ID: 16480265
[TBL] [Abstract][Full Text] [Related]
17. Nanomolar competitive inhibitors of Mycobacterium tuberculosis and Streptomyces coelicolor type II dehydroquinase.
Prazeres VF; Sánchez-Sixto C; Castedo L; Lamb H; Hawkins AR; Riboldi-Tunnicliffe A; Coggins JR; Lapthorn AJ; González-Bello C
ChemMedChem; 2007 Feb; 2(2):194-207. PubMed ID: 17245805
[TBL] [Abstract][Full Text] [Related]
18. Mechanistic basis of the inhibition of type II dehydroquinase by (2S)- and (2R)-2-benzyl-3-dehydroquinic acids.
Lence E; Tizón L; Otero JM; Peón A; Prazeres VF; Llamas-Saiz AL; Fox GC; van Raaij MJ; Lamb H; Hawkins AR; González-Bello C
ACS Chem Biol; 2013 Mar; 8(3):568-77. PubMed ID: 23198883
[TBL] [Abstract][Full Text] [Related]
19. The two types of 3-dehydroquinase have distinct structures but catalyze the same overall reaction.
Gourley DG; Shrive AK; Polikarpov I; Krell T; Coggins JR; Hawkins AR; Isaacs NW; Sawyer L
Nat Struct Biol; 1999 Jun; 6(6):521-5. PubMed ID: 10360352
[TBL] [Abstract][Full Text] [Related]
20. Design and structural analysis of aromatic inhibitors of type II dehydroquinase from Mycobacterium tuberculosis.
Howard NI; Dias MV; Peyrot F; Chen L; Schmidt MF; Blundell TL; Abell C
ChemMedChem; 2015 Jan; 10(1):116-33. PubMed ID: 25234229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
